Novartis AG

Novartis AGverified

NVS

Price:

$105.72

Market Cap:

$206.84B

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients an...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1996-11-07

Stock Exchange

NYSE

Ticker

NVS

The ROE as of June 2024 (TTM) for Novartis AG (NVS) is 34.58%

According to Novartis AG’s latest financial reports and current stock price. The company's current ROE is 34.58%. This represents a change of 306.47% compared to the average of 8.51% of the last 4 quarters.

Novartis AG (NVS) Historical ROE (quarterly & annually)

How has NVS ROE performed in the past?

The mean historical ROE of Novartis AG over the last ten years is 17.91%. The current 34.58% ROE has changed 93.07% with respect to the historical average. Over the past ten years (40 quarters), NVS's ROE was at its highest in in the December 2021 quarter at 24.10%. The ROE was at its lowest in in the December 2016 quarter at 1.28%.

Quarterly (TTM)
Annual

Average

17.91%

Median

14.34%

Minimum

8.97%

Maximum

35.51%

Novartis AG (NVS) ROE by Quarter and Year

Discovering the peaks and valleys of Novartis AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 171.51%

Maximum Annual ROE = 35.51%

Minimum Annual Increase = -66.99%

Minimum Annual ROE = 8.97%

Quarterly (TTM)
Annual
YearROEChange
202331.82%171.51%
202211.72%-66.99%
202135.51%148.95%
202014.26%10.70%
201912.88%-19.69%
201816.04%54.46%
201710.39%15.79%
20168.97%-61.14%
201523.08%59.98%
201414.43%16.91%

Novartis AG (NVS) Average ROE

How has NVS ROE performed in the past?

The current ROE of Novartis AG (NVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

26.35%

5-year avg

21.24%

10-year avg

17.91%

Novartis AG (NVS) ROE vs. Peers

How is NVS’s ROE compared to its peers?

Novartis AG’s ROE is less than AstraZeneca PLC (16.75%), less than GSK plc (33.83%), less than Roche Holding AG (61.78%), greater than Bristol-Myers Squibb Company (-23.01%), less than Sanofi (9.61%), less than Merck & Co., Inc. (5.84%), greater than Bayer Aktiengesellschaft (-8.98%), less than Gilead Sciences, Inc. (2.32%), less than Johnson & Johnson (53.97%), less than AbbVie Inc. (55.33%), less than Eli Lilly and Company (53.53%), greater than Pfizer Inc. (-0.31%),

CompanyROEMarket cap
16.75%$246.77B
33.83%$82.89B
61.78%$223.99B
-23.01%$83.52B
9.61%$115.89B
5.84%$327.95B
-8.98%$28.45B
2.32%$81.06B
53.97%$350.27B
55.33%$297.71B
53.53%$834.88B
-0.31%$156.00B

Build a custom stock screener for Novartis AG (NVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novartis AG (NVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Novartis AG's ROE?

How is the ROE calculated for Novartis AG (NVS)?

What is the highest ROE for Novartis AG (NVS)?

What is the 3-year average ROE for Novartis AG (NVS)?

What is the 5-year average ROE for Novartis AG (NVS)?

How does the current ROE for Novartis AG (NVS) compare to its historical average?